Antonio Ruiz-Garcia
Overview
Explore the profile of Antonio Ruiz-Garcia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
208
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ruiz-Garcia A, Serrano-Cumplido A, Escobar-Cervantes C, Arranz-Martinez E, Pallares-Carratala V
Nutrients
. 2024 Nov;
16(22).
PMID: 39599733
Background/objective: In addition to obesity, adiposity and abdominal obesity (AO) are parameters included in the cardiovascular-kidney-metabolic (CKM) syndrome. However, their prevalence and association with the other CKM factors have been...
2.
Ruiz-Garcia A, Serrano-Cumplido A, Escobar-Cervantes C, Arranz-Martinez E, Pallares-Carratala V
Medicina (Kaunas)
. 2024 Aug;
60(8).
PMID: 39202590
Atrial fibrillation (AF) is the most frequent arrhythmia and the main cause of hospital admissions for cardioembolic stroke. The SIMETAP research project aims to update the prevalence rates of cardiovascular,...
3.
Ruiz-Garcia A, Serrano-Cumplido A, Arranz-Martinez E, Escobar-Cervantes C, Pallares-Carratala V
J Clin Med
. 2024 Aug;
13(16).
PMID: 39201026
Scientific societies disagree on serum uric acid (SUA) thresholds for the diagnosis of hyperuricaemia (HU) according to epidemiological or physiochemical criteria (SUA ≥ 7.0 mg/dL for men and ≥6.0 mg/dL...
4.
Pallares-Carratala V, Ruiz-Garcia A, Serrano-Cumplido A, Fragoso A, Fernandez-Pascual V, Sanchez-Sanchez B, et al.
Clin Investig Arterioscler
. 2024 Jun;
37(1):100724.
PMID: 38910079
Introduction: Type 2 diabetes mellitus (T2D) has acquired epidemic proportions worldwide. In recent years, new oral glucose-lowering drugs (OGLD) have emerged that improve the cardiovascular-kidney-metabolic control in T2D people. Objectives:...
5.
Pallares-Carratala V, Ruiz-Garcia A, Serrano-Cumplido A, Arranz-Martinez E, Divison-Garrote J, Moya-Amengual A, et al.
Medicina (Kaunas)
. 2023 Oct;
59(10).
PMID: 37893564
: Arterial hypertension (HTN) is the leading preventable cause of atherosclerotic cardiovascular diseases (ASCVD) and death from all causes. This study aimed to determine the prevalence rates of HTN diagnosed...
6.
Ruiz-Garcia A, Serrano-Cumplido A, Escobar-Cervantes C, Arranz-Martinez E, Turegano-Yedro M, Pallares-Carratala V
J Clin Med
. 2023 Aug;
12(15).
PMID: 37568326
Introduction And Objectives: Heart failure (HF) is a major health problem that causes high mortality and hospitalization rates. This study aims to determine the HF prevalence rates in populations aged...
7.
Moya-Amengual A, Ruiz-Garcia A, Pallares-Carratala V, Serrano-Cumplido A, Prieto-Diaz M, Segura-Fragoso A, et al.
Front Cardiovasc Med
. 2023 May;
10:1090458.
PMID: 37229234
Introduction: Elevated pulse pressure (ePP) is an independent marker of cardiovascular risk (CVR) in people older than 60, and a functional marker of subclinical target organ damage (sTOD) which can...
8.
Ruiz-Garcia A, Pallares-Carratala V, Turegano-Yedro M, Torres F, Sapena V, Martin-Gorgojo A, et al.
Nutrients
. 2023 Apr;
15(8).
PMID: 37111028
Background: The impact of vitamin D supplementation on cardiovascular outcomes and mortality risk reduction remains unclear due to conflicting study findings. Methods: We conducted a systematic review and meta-analysis of...
9.
Ruiz-Garcia A, Lara-Rodriguez A, Garzon A, Zamora-Munoz C
Zootaxa
. 2023 Apr;
5219(6):583-592.
PMID: 37044548
In this paper we describe the main morphological characteristics that distinguish the full-grown larva of Erotesis schachti, an endemic of the Iberian Peninsula. The conspecificity of the larva and adult...
10.
Gonzalez-Gallardo C, Martinez-Atienza J, Mataix B, Munoz-Avila J, Daniel Martinez-Rodriguez J, Medialdea S, et al.
Biomed Pharmacother
. 2023 Mar;
162:114612.
PMID: 36989713
Objectives: Corneal diseases are among the main causes of blindness, with approximately 4.6 and 23 million patients worldwide suffering from bilateral and unilateral corneal blindness, respectively. The standard treatment for...